Healthcare AI Acquisition Corp. Warrants
HAIAW
HAIAW was delisted on the 12th of December, 2024.
0 hedge funds and large institutions have $0 invested in Healthcare AI Acquisition Corp. Warrants in 2025 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 3 closing their positions.
100% less funds holding
Funds holding: 3 → 0 (-3)
100% less capital invested
Capital invested by funds: $719K → $0 (-$719K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
-$718K |
| 2 |
RCM
Rivernorth Capital Management
West Palm Beach,
Florida
|
-$642 |
| 3 |
CCM
Context Capital Management
Lajolla,
California
|
-$119 |
HAIAW Hedge Fund Activity: Q1 2025 in Review
0 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Healthcare AI Acquisition Corp. Warrants (HAIAW) for Q1 2025, worth a combined $0 — down 100% from $719K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of HAIAW and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Barclays, exiting entirely with an estimated $718K sold.
- 0 institutional investors held Healthcare AI Acquisition Corp. Warrants (HAIAW) as of Q1 2025, down from 3 in Q4 2024.
- Funds reported $0 of Healthcare AI Acquisition Corp. Warrants stock for Q1 2025, down 100% quarter-over-quarter.
- 0 funds opened new Healthcare AI Acquisition Corp. Warrants positions in Q1 2025 and 3 closed out, a net change of -3 holders.
- The largest Healthcare AI Acquisition Corp. Warrants seller in Q1 2025 was Barclays, an estimated $718K sold.
Based on aggregated 13F filings for Q1 2025.